When available, the use of CRP combined with otherbiomarkers including procalcitonin (PCT), IL-6 and IL-8 to increase itsspecificity in the diagnosis of infections(16,17) and toassess changes in changes in therapeutic approaches, including changes inantibiotic therapy, is also promising. The gene discussed is CALCA; the disease is infection.